Cargando…
Break Breast Cancer Addiction by CRISPR/Cas9 Genome Editing
Breast cancer is the leading diagnosed cancer for women globally. Evolution of breast cancer in tumorigenesis, metastasis and treatment resistance appears to be driven by the aberrant gene expression and protein degradation encoded by the cancer genomes. The uncontrolled cancer growth relies on thes...
Autores principales: | Yang, Haitao, Jaeger, MariaLynn, Walker, Averi, Wei, Daniel, Leiker, Katie, Weitao, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771328/ https://www.ncbi.nlm.nih.gov/pubmed/29344267 http://dx.doi.org/10.7150/jca.22554 |
Ejemplares similares
-
Genome editing of Clostridium autoethanogenum using CRISPR/Cas9
por: Nagaraju, Shilpa, et al.
Publicado: (2016) -
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021) -
Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015) -
Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015) -
CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)